Sage Journals: Discover world-class research

Open access

Research article

First published 2022

Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening

Wesley Schaal, Adam Ameur, Ulla Olsson-Strömberg [...]

Cancer Informatics

Retricted access

Research article

First published 2013-02

BCR-ABL1 Kinase Domain Mutation Analysis in an Irish Cohort of Chronic Myeloid Leukemia Patients

Sarah L. McCarron, Lisa M. O'Connor, Stephen E. Langabeer [...]

Genetic Testing and Molecular Biomarkers

Free access

Review article

First published 2014-8

Practical management of patients with chronic myeloid leukemia who develop tyrosine kinase inhibitor-resistant BCR-ABL1 mutations

Jing Ai, Ramon V. Tiu

Therapeutic Advances in Hematology

Open access

Case report

First published 2020

A rare atypical chronic myeloid leukemia BCR-ABL1 negative with concomitant JAK2 V617F and SETBP1 mutations: a case report and literature review

Tianqi Gao, Changhui Yu, Si Xia [...]

Therapeutic Advances in Hematology

Free access

Review article

First published 2016-10

Current developments in molecular monitoring in chronic myeloid leukemia

Justine Ellen Marum, Susan Branford

Therapeutic Advances in Hematology

Free access

Research article

First published 2010-11

Plasma tyrosine kinase activity as a potential biomarker in BCR-ABL1-targeted therapy

Chen-Hsiung Yeh, Adam Abdool, Jean-Marie Bruey

Cancer Biomarkers

Retricted access

Case report

First published 2020-4

Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Kartik Viswanathan, Gail Roboz, Amy Chadburn [...]

International Journal of Surgical Pathology

Retricted access

Case report

First published 2021-10

Co-existence of BCR-ABL and JAK2V617F mutation in resistant chronic myeloid leukemia in the imatinib era: Is there a correlation?

Rim Frikha, Fatma Turki, Olfa Kassar [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2013-2

Comprehensive review of JAK inhibitors in myeloproliferative neoplasms

Mohamad Bassam Sonbol, Belal Firwana, Ahmad Zarzour [...]

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2021-08

CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia

Elena Vuelta, José Luis Ordoñez, Verónica Alonso-Pérez [...]

The CRISPR Journal

Search results